Free Trial

Aflac Incorporated $AFL Stock Position Lifted by Callan Family Office LLC

Aflac logo with Finance background

Key Points

  • Callan Family Office LLC increased its stake in Aflac by 163.5% during the second quarter, holding 25,821 shares worth approximately $2,723,000.
  • Wall Street analysts have mixed ratings on Aflac, with a consensus target price of $109.45, as three analysts rated it as a Buy, seven as Hold, and two as Sell.
  • Aflac recently announced a quarterly dividend of $0.58 per share, alongside a stock repurchase program authorizing the buyback of 100 million shares.
  • Interested in Aflac? Here are five stocks we like better.

Callan Family Office LLC grew its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 163.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,821 shares of the financial services provider's stock after buying an additional 16,020 shares during the period. Callan Family Office LLC's holdings in Aflac were worth $2,723,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of AFL. AlphaCore Capital LLC bought a new stake in shares of Aflac in the 1st quarter worth approximately $28,000. Hilltop National Bank bought a new stake in shares of Aflac in the 2nd quarter worth approximately $32,000. Golden State Wealth Management LLC lifted its holdings in shares of Aflac by 121.9% in the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock worth $34,000 after purchasing an additional 167 shares during the last quarter. Groupe la Francaise bought a new stake in shares of Aflac in the 1st quarter worth approximately $34,000. Finally, Garde Capital Inc. bought a new stake in shares of Aflac in the 1st quarter worth approximately $36,000. Institutional investors own 67.44% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Keefe, Bruyette & Woods raised their price target on Aflac from $108.00 to $110.00 and gave the stock a "market perform" rating in a report on Thursday. Weiss Ratings reissued a "buy (b-)" rating on shares of Aflac in a report on Wednesday. Evercore ISI set a $110.00 target price on Aflac and gave the company an "underperform" rating in a research note on Thursday. Wells Fargo & Company lifted their target price on Aflac from $105.00 to $107.00 and gave the company an "equal weight" rating in a research note on Monday, August 11th. Finally, UBS Group cut their target price on Aflac from $114.00 to $111.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $109.45.

Check Out Our Latest Stock Analysis on AFL

Aflac Stock Down 0.4%

Shares of AFL stock opened at $110.78 on Friday. Aflac Incorporated has a 1 year low of $96.95 and a 1 year high of $115.44. The stock has a market cap of $59.25 billion, a PE ratio of 25.12, a price-to-earnings-growth ratio of 3.08 and a beta of 0.86. The business's fifty day moving average is $107.55 and its 200-day moving average is $105.48. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.11 and a current ratio of 0.11.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The company had revenue of $5.91 billion for the quarter. Equities analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th were paid a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, August 20th. This represents a $2.32 annualized dividend and a dividend yield of 2.1%. Aflac's dividend payout ratio (DPR) is currently 52.61%.

Aflac announced that its board has authorized a stock repurchase program on Tuesday, August 12th that authorizes the company to buyback 100,000,000 shares. This buyback authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company's leadership believes its stock is undervalued.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $102.57, for a total transaction of $102,570.00. Following the completion of the sale, the director directly owned 25,105 shares of the company's stock, valued at $2,575,019.85. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.90% of the stock is currently owned by corporate insiders.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aflac Right Now?

Before you consider Aflac, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.

While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.